Autres langues Ascendis Pharma A/S

Actions

ASND

US04351P1012

Temps réel estimé Cboe BZX Autres places de cotation 18:48:42 18/04/2024			Varia. 5j.	Varia. 1 janv.
142,7 ^USD	+0,38 %		-5,20 %	+13,68 %

17:23	Les actions européennes négociées aux Etats-Unis et les American Depositary Receipts sont restés stables jeudi matin	MT
02/04	ASCENDIS PHARMA A/S : JPMorgan Chase persiste à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	17:23
Ascendis Pharma A/S : Form 6-K	10/04
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28/03
Ascendis Pharma A/S : Form 6-K	27/03
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21/03
Ascendis Pharma A/S : Form 6-K	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	12/03
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024	04/03
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer	29/02
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading	16/02
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	09/02
Ascendis Pharma Q4 Net Loss Narrows, Revenue Rises	07/02
Earnings Flash (ASND) ASCENDIS PHARMA Posts Q4 Revenue EUR137.7M	07/02
Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results	07/02
Ascendis Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/02
Ascendis Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023	07/02
Ascendis Pharma to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02
European Equities Traded in the US as American Depositary Receipts Make Modest Gains in Thursday Trading	01/02
Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024	31/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ascendis Pharma A/S

Actions

ASND

US04351P1012

Autres langues

Filtres